New Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Buy
340
+14
+4% +$14.3K 0.09% 44
2026
Q1
$300K Hold
326
0.07% 52
2025
Q4
$350K Hold
326
0.09% 47
2025
Q3
$249K Buy
326
+40
+14% +$29.8K 0.07% 50
2025
Q2
$223K Buy
+286
New +$222K 0.06% 53

Other funds holding LLY

New Capital Management's LLY Position: Q2 2026 in Review

New Capital Management increased its Eli Lilly (LLY) stake by 4.3% in Q2 2026, buying an estimated $14.3K and bringing the position to 340 shares worth $408K. The position accounts for 0.09% of the portfolio, ranked #44.

New Capital Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • New Capital Management held 340 shares of Eli Lilly worth $408K as of Q2 2026.
  • New Capital Management bought 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
  • Eli Lilly made up 0.09% of New Capital Management's portfolio in Q2 2026, its #44 holding.
  • New Capital Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on New Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.